Lv51
1240 积分 2024-03-28 加入
Critical evaluation of therapeutic targeting in chronic kidney disease: where do we stand 5 years on?
15天前
已完结
Clinical Pattern of Tolvaptan-Associated Liver Injury in Trial Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Analysis of Pivotal Clinical Trials
15天前
已关闭
Next-generation therapeutics for diabetic kidney disease
15天前
已完结
Dapagliflozin in Patients with Chronic Kidney Disease
19天前
已完结
Targeting new cellular disease pathways in autosomal dominant polycystic kidney disease
29天前
已完结
Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease
29天前
已完结
Why kidneys fail in autosomal dominant polycystic kidney disease
30天前
已完结
Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study
30天前
已完结
Polycystic Kidney Disease without an Apparent Family History
30天前
已完结
Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage
30天前
已完结
皖公网安备34019202002308
